ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.00578566967432525 0.3349926
NSC 649150 Null 0.00578566967432525 0.16614004
NSC 655105 Cycloshikonin 0.00578566967432525 0.38807295
NSC 656211 Null 0.00578566967432525 0.34711562
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.00578566967432525 0.31993264
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.00578566967432525 0.37237755
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.00578566967432525 0.067959786
NSC 154829 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride 0.00645628049634952 0.41749166
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.00645628049634952 0.27217282
NSC 250682 Oridonin 0.00645628049634952 0.11682477
Total:126  Current:29    [First] [Prev] [Next] [Last]